1
melanoma BRAF (E586K) 64-year-old female 
[0, 0, 0.18266710951995763, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
2
cholangiocarcinoma BRAF (V600E) 64-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
3
prostate cancer ATM deletion 50-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
4
gastric cancer ERBB2 amplification 64-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
5
cervical cancer ERBB2 (S310Y) 45-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0.022746338630123597, 0, 0]
6
non-small cell lung cancer EGFR (D770N) 54-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0.22172825269652433, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
7
non-small cell lung cancer EGFR (T790M) 50-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.22172825269652433, 0, 0, 0, 0, 0, 0, 0]
8
bladder cancer FGFR3 (S249C) 64-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
9
gastrointestinal stromal tumor KIT (exon 9 502_503 duplication) 58-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.14375700303550812, 0, 0, 0, 0, 0, 0, 0, 0, 0.13901945161716817, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.002188644666846173, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
10
mucosal melanoma KIT (L576P), KIT amplification 62-year-old female 
[0, 0, 0.18266710951995763, 0, 0, 0, 0.0334378131623635, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
11
gastrointestinal stromal tumor PDGFRA (D842V) 56-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0.005362914046993976, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.14375700303550812, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0.13901945161716817, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.002188644666846173, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
12
inflammatory myofibroblastic tumor RANBP2-ALK fusion 32-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
13
lung adenocarcinoma EZR-ROS1 fusion 72-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.03594705432364694, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
14
colon cancer MLH1 methylation suppression (microsatellite instability) 68-year-old male 
[0, 0, 0, 0, 0, 0, 0.008379492320593887, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
15
lung adenocarcinoma KRAS (G12V), high tumor mutational burden 57-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.0869750074737729, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.05056886400800292, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
16
papillary thyroid carcinoma BRAF (V600E) 51-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0.4827382168485874, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
17
glioblastoma IDH1 (R132H) 50-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
18
lung adenocarcinoma SND1-BRAF fusion 54-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
19
colon cancer ERBB2 amplification 45-year-old female 
[0, 0, 0, 0, 0, 0, 0.008379492320593887, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
20
pancreatic cancer BRCA2 50-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
21
gastrointestinal stromal tumor KIT (V654A) 70-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.14375700303550812, 0, 0, 0, 0, 0, 0, 0, 0, 0.13901945161716817, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.002188644666846173, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
22
colon cancer PIK3CA (E545K) 45-year-old female 
[0, 0, 0, 0, 0, 0, 0.008379492320593887, 0, 0, 0, 0, 0.8799079730957308, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
23
breast cancer AURKA amplification 70-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
24
cholangiocarcinoma PIK3CA (1047H) 62-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
25
melanoma NRAS (Q61H) 32-year-old male 
[0, 0, 0.18266710951995763, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
26
squamous cell lung cancer FGFR1 amplification 65-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
27
non-small cell lung cancer KRAS (G12C) 70-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.22172825269652433, 0, 0, 0, 0, 0, 0, 0]
28
ovarian cancer BRCA1 64-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
29
chondrosarcoma IDH1 26-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
30
endometrial cancer PIK3R1 58-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0.005783778337472798, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
31
aortic aneurysm ACTA2 63-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.004840590538282967, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
32
Loeys-Dietz syndrome TGFBR2 42-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
33
long QT syndrome KCNQ1 15-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
34
Brugada syndrome SCN5A 36-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
35
familial hypercholesterolemia PCSK9 24-year-old female 
[0, 0, 0, 0, 0, 0.01122881827927573, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0.015514693506280416, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
36
Li-Fraumeni syndrome TP53 14-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
37
dilated cardiomyopathy LMNA 32-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
38
Peutz-Jeghers syndrome STK11 11-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
39
long QT syndrome KCNH2 19-year-old female 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.34276925890974796, 0, 0, 0, 0, 0, 0, 0, 0, 0.004600460548185271, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0, 0, 0, 0.04918302984984356, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.016057551630559396, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.054367076580574686, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.11727167764091949, 0, 0, 0, 0]
40
malignant hyperthermia RYR1 54-year-old male 
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0.12418924648665246, 0, 0, 0.42278835553204813, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
